Humacyte, Inc.
HUMA
$1.29
$0.032.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.51M | -37.66M | 39.14M | -20.94M | -39.20M |
| Total Depreciation and Amortization | 1.87M | 1.86M | 1.83M | 1.81M | 1.81M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.14M | 10.78M | -60.01M | -4.94M | 11.07M |
| Change in Net Operating Assets | -4.12M | -1.40M | -9.56M | -2.50M | 3.41M |
| Cash from Operations | -23.90M | -26.41M | -28.60M | -26.58M | -22.91M |
| Capital Expenditure | -49.00K | -568.00K | -228.00K | -63.00K | -934.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -49.00K | -568.00K | -228.00K | -63.00K | -934.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -743.00K | -727.00K | -687.00K | -673.00K | -659.00K |
| Issuance of Common Stock | 6.20M | 3.23M | 47.43M | 50.16M | 495.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.05M | -340.00K | -- | 1.52M | 1.01M |
| Cash from Financing | -44.59M | 2.17M | 46.74M | 51.01M | 849.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -68.54M | -24.82M | 17.91M | 24.37M | -22.99M |